The sun illuminates the Supreme Court in Washington, DC, on January 17.
Julia Nikhinson/Bloomberg/Getty Images
The Supreme Court will consider whether to restrict access to a widely used abortion drug on Tuesday. Central to the dispute is the scope of the US Food and Drug Administration’s authority to regulate mifepristone, a drug that the medical community has deemed safe and effective.
The drug was initially approved by the FDA in 2000, but in 2016, 2019 and 2021, the FDA put in place modifications that would make the drug more easily accessible. Those modifications
